Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Operating Expenses (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Operating Expenses for 16 consecutive years, with $163.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 12.57% to $163.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $680.8 million, a 10.77% increase, with the full-year FY2024 number at $627.0 million, down 3.73% from a year prior.
  • Operating Expenses was $163.6 million for Q3 2025 at Usana Health Sciences, down from $168.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $248.3 million in Q1 2022 to a low of $66.6 million in Q4 2021.
  • A 5-year average of $162.2 million and a median of $164.1 million in 2022 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: plummeted 66.14% in 2021, then skyrocketed 156.91% in 2022.
  • Usana Health Sciences' Operating Expenses stood at $66.6 million in 2021, then surged by 138.55% to $159.0 million in 2022, then dropped by 2.79% to $154.5 million in 2023, then grew by 7.96% to $166.8 million in 2024, then fell by 1.93% to $163.6 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Operating Expenses are $163.6 million (Q3 2025), $168.9 million (Q2 2025), and $181.4 million (Q1 2025).